866 related articles for article (PubMed ID: 3141506)
1. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function.
Fischer HG; Frosch S; Reske K; Reske-Kunz AB
J Immunol; 1988 Dec; 141(11):3882-8. PubMed ID: 3141506
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte-macrophage colony-stimulating factor-cultured bone marrow-derived macrophages reveal accessory cell function and synthesis of MHC class II determinants in the absence of external stimuli.
Fischer HG; Opel B; Reske K; Reske-Kunz AB
Eur J Immunol; 1988 Aug; 18(8):1151-8. PubMed ID: 3138135
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Ia antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor.
Falk LA; Wahl LM; Vogel SN
J Immunol; 1988 Apr; 140(8):2652-60. PubMed ID: 3128601
[TBL] [Abstract][Full Text] [Related]
4. Induction of antigen presentation capacity and MHC class II gene expression in bone marrow macrophages derived from GM-CSF-supplemented in vitro cultures.
Reske-Kunz AB; Fischer HG; Reske K
Behring Inst Mitt; 1988 Aug; (83):258-64. PubMed ID: 2467653
[TBL] [Abstract][Full Text] [Related]
5. The efficient bovine insulin presentation capacity of bone marrow-derived macrophages activated by granulocyte-macrophage colony-stimulating factor correlates with a high level of intracellular reducing thiols.
Frosch S; Bonifas U; Eck HP; Bockstette M; Droege W; Rüde E; Reske-Kunz AB
Eur J Immunol; 1993 Jul; 23(7):1430-4. PubMed ID: 8325319
[TBL] [Abstract][Full Text] [Related]
6. Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor.
Gajewski TF; Goldwasser E; Fitch FW
J Immunol; 1988 Oct; 141(8):2635-42. PubMed ID: 2971726
[TBL] [Abstract][Full Text] [Related]
7. Recombinant granulocyte-macrophage colony-stimulating factor restores deficient immune responses in mice with chronic Trypanosoma cruzi infections.
Reed SG; Grabstein KH; Pihl DL; Morrissey PJ
J Immunol; 1990 Sep; 145(5):1564-70. PubMed ID: 2117033
[TBL] [Abstract][Full Text] [Related]
8. Presentation of soluble antigens by mast cells: upregulation by interleukin-4 and granulocyte/macrophage colony-stimulating factor and downregulation by interferon-gamma.
Frandji P; Tkaczyk C; Oskéritzian C; Lapeyre J; Peronet R; David B; Guillet JG; Mécheri S
Cell Immunol; 1995 Jun; 163(1):37-46. PubMed ID: 7758129
[TBL] [Abstract][Full Text] [Related]
9. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
Ferret-Bernard S; Saï P; Bach JM
Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
[TBL] [Abstract][Full Text] [Related]
10. Tumor growth changes responsiveness to and production of granulocyte-macrophage colony-stimulating factor during recognition of self MHC class II molecules.
Walker TM; Burger CJ; Elgert KD
Oncol Res; 1992; 4(11-12):455-65. PubMed ID: 1299376
[TBL] [Abstract][Full Text] [Related]
11. Regulation of macrophage activation by IL-3. I. IL-3 functions as a macrophage-activating factor with unique properties, inducing Ia and lymphocyte function-associated antigen-1 but not cytotoxicity.
Frendl G; Beller DI
J Immunol; 1990 May; 144(9):3392-9. PubMed ID: 2158509
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and expression of MHC class II molecules in the absence of attached invariant chains by recombinant-interferon-gamma-activated bone-marrow-derived macrophages.
Schneider FJ; Opel B; Ballhausen W; Henkes W; Steinlein P; Reske K
Eur J Immunol; 1987 Sep; 17(9):1235-42. PubMed ID: 3115789
[TBL] [Abstract][Full Text] [Related]
13. Selective culture of primate marrow-derived macrophages in medium devoid of protein additives.
Patel JM; Keene PA; Ross FP; Loubser MD; Mendelow BV
Exp Hematol; 1989 Feb; 17(2):96-101. PubMed ID: 2643521
[TBL] [Abstract][Full Text] [Related]
14. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice.
Serreze DV; Gaskins HR; Leiter EH
J Immunol; 1993 Mar; 150(6):2534-43. PubMed ID: 8450229
[TBL] [Abstract][Full Text] [Related]
15. Amplification of IL-2-driven T cell proliferation by recombinant human IL-3 and granulocyte-macrophage colony-stimulating factor.
Santoli D; Clark SC; Kreider BL; Maslin PA; Rovera G
J Immunol; 1988 Jul; 141(2):519-26. PubMed ID: 3290340
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow macrophages induced to antigen presentation by lymphokines interact selectively with distinct T cells.
Fischer HG; Reske-Kunz AB; Spaeth E; Rüde E
Eur J Immunol; 1985 Sep; 15(9):957-60. PubMed ID: 3876225
[TBL] [Abstract][Full Text] [Related]
17. Potentiating effect of granulocyte-macrophage colony-stimulating factor on interleukin-1-induced thymocyte proliferation: evidence for an interleukin-2 and tumor necrosis factor-independent pathway.
Herbelin A; Machavoine F; Dy M
Lymphokine Res; 1990; 9(2):155-65. PubMed ID: 2187117
[TBL] [Abstract][Full Text] [Related]
18. Biochemical events accompanying macrophage activation and the inhibition of colony-stimulating factor-1-induced macrophage proliferation by tumor necrosis factor-alpha, interferon-gamma, and lipopolysaccharide.
Vairo G; Royston AK; Hamilton JA
J Cell Physiol; 1992 Jun; 151(3):630-41. PubMed ID: 1338337
[TBL] [Abstract][Full Text] [Related]
19. Evidence for effects of interleukin 4 (B cell stimulatory factor 1) on macrophages: enhancement of antigen presenting ability of bone marrow-derived macrophages.
Zlotnik A; Fischer M; Roehm N; Zipori D
J Immunol; 1987 Jun; 138(12):4275-9. PubMed ID: 3495588
[TBL] [Abstract][Full Text] [Related]
20. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
Geppert TD; Lipsky PE
J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
